Article
SORORIN is an evolutionary conserved antagonist of WAPL
medRxiv · 2022 · Ignacio Prusén Mota, author Marta Galova, author Alexander Schleiffer, author Tan-Trung Nguyen, author Ines Kovacikova, author Tomoko Nishiyama, author Juraj Gregan, author Jan-Michael Peters, author Peter Schlögelhofer, author
Key facts
| Title | SORORIN is an evolutionary conserved antagonist of WAPL |
|---|---|
| First author | Ignacio Prusén Mota, author Marta Galova, author Alexander Schleiffer, author Tan-Trung Nguyen, author Ines Kovacikova, author Tomoko Nishiyama, author Juraj Gregan, author Jan-Michael Peters, author Peter Schlögelhofer, author |
| Journal | medRxiv |
| Published | Oct 27, 2022 |
| DOI | 10.1101/2022.10.24.513534 |
| Devices mentioned | K042884 |
| Product codes mentioned | KPA, MVU, MYA, MXZ, NJT, NKF |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1